Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Integer Holdings Corp (ITGR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: ITGR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -2.71% | Avg. Invested days 57 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.15B USD | Price to earnings Ratio 34.71 | 1Y Target Price 154.5 |
Price to earnings Ratio 34.71 | 1Y Target Price 154.5 | ||
Volume (30-day avg) 613673 | Beta 1.25 | 52 Weeks Range 107.11 - 146.36 | Updated Date 04/1/2025 |
52 Weeks Range 107.11 - 146.36 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.99% | Operating Margin (TTM) 13.09% |
Management Effectiveness
Return on Assets (TTM) 4.64% | Return on Equity (TTM) 7.72% |
Valuation
Trailing PE 34.71 | Forward PE 22.88 | Enterprise Value 5207533591 | Price to Sales(TTM) 2.42 |
Enterprise Value 5207533591 | Price to Sales(TTM) 2.42 | ||
Enterprise Value to Revenue 3.03 | Enterprise Value to EBITDA 16.75 | Shares Outstanding 35171200 | Shares Floating 32963496 |
Shares Outstanding 35171200 | Shares Floating 32963496 | ||
Percent Insiders 1.85 | Percent Institutions 121.16 |
Analyst Ratings
Rating 4.67 | Target Price 146.88 | Buy 1 | Strong Buy 7 |
Buy 1 | Strong Buy 7 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Integer Holdings Corp
Company Overview
History and Background
Integer Holdings Corp., formerly Greatbatch, Inc., was founded in 1970. Initially focused on battery technology for pacemakers, it has evolved into a leading medical device outsource manufacturer. The company has expanded through strategic acquisitions and organic growth to offer a broad portfolio of products and services.
Core Business Areas
- Cardiovascular: Develops and manufactures components and subassemblies for cardiac rhythm management, cardiac surgery, and vascular applications. Examples include leads, delivery systems, and diagnostic catheters.
- Medical: Produces components and devices for neuromodulation, orthopedic, and other medical applications. This segment includes stimulation leads, spinal cord stimulators, and advanced surgical solutions.
- Battery: Designs and manufactures advanced battery technologies for medical devices, energy, and other specialized applications. This includes implantable and portable medical device batteries.
Leadership and Structure
Integer Holdings Corp. is led by a CEO and a senior management team responsible for overseeing various business functions. The organizational structure is divided into business segments, each with dedicated management and operations teams.
Top Products and Market Share
Key Offerings
- Cardiac Rhythm Management Leads: Integer manufactures leads used in pacemakers and defibrillators. They hold a significant portion of the outsourced lead market. Competitors include Medtronic, Abbott, and Boston Scientific who all in-house manufacture a large portion of their lead needs
- Market Share:
- Implantable Batteries: Integer designs and manufactures implantable batteries used in a variety of medical devices. Competitors include EaglePicher Technologies, and Electrochem.
- Market Share:
- Delivery Systems: Catheters and delivery systems for various cardiovascular and neurovascular procedures. They are a leading outsourcing partner for these devices. Competitors include Teleflex and Boston Scientific
- Market Share:
Market Dynamics
Industry Overview
The medical device outsourcing market is driven by factors such as increasing healthcare spending, technological advancements, and the growing demand for minimally invasive procedures. The industry is highly regulated and competitive, with a focus on innovation and quality.
Positioning
Integer Holdings Corp. is a leading player in the medical device outsourcing market, known for its engineering expertise, manufacturing capabilities, and regulatory compliance. They serve both established medical device companies and emerging innovators.
Total Addressable Market (TAM)
The global medical device outsourcing market is estimated at hundreds of billions of dollars. Integer is positioned to capture a significant portion of this market through its diverse product portfolio and strong customer relationships.
Upturn SWOT Analysis
Strengths
- Strong market position
- Diversified product portfolio
- Engineering expertise
- Manufacturing capabilities
- Strong customer relationships
Weaknesses
- Customer concentration
- Exposure to regulatory changes
- Potential for product liability claims
- Dependency on key suppliers
Opportunities
- Expanding into new markets
- Developing innovative products
- Acquiring complementary businesses
- Benefiting from aging population
Threats
- Increased competition
- Economic downturns
- Product recalls
- Disruptive technologies
Competitors and Market Share
Key Competitors
- Cantel Medical (Now STERIS) (STE)
- Natus Medical Incorporated (NTUS)
Competitive Landscape
Integer benefits from specialized manufacturing and engineering capabilities in certain niches, giving it an advantage over larger, more diversified competitors. However, these larger companies have greater financial resources.
Major Acquisitions
Lake Region Medical
- Year: 2015
- Acquisition Price (USD millions): 1725
- Strategic Rationale: Expanded Integer's capabilities in complex medical devices and components.
Growth Trajectory and Initiatives
Historical Growth: Integer has grown organically and through acquisitions, expanding its product portfolio and market presence.
Future Projections: Analysts project continued revenue and earnings growth for Integer, driven by its strong market position and increasing demand for medical device outsourcing.
Recent Initiatives: Recent initiatives include investments in R&D, expansion of manufacturing capacity, and strategic acquisitions.
Summary
Integer Holdings is a strong player in the medical device outsourcing market with a diversified product portfolio. Its engineering expertise and manufacturing capabilities are key strengths. Customer concentration and regulatory changes pose potential challenges. Strategic acquisitions are expected to drive future growth.
Similar Companies
- STE
- NTUS
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Integer Holdings Corp
Exchange NYSE | Headquaters Plano, TX, United States | ||
IPO Launch date 2000-09-29 | President, CEO & Director Mr. Joseph W. Dziedzic | ||
Sector Healthcare | Industry Medical Devices | Full time employees 11000 | Website https://www.integer.net |
Full time employees 11000 | Website https://www.integer.net | ||
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.